Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Patrick Flochel

Member of the Supervisory Board @Access to Medicine Foundation

Zurich, CH
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Dec 2021 — Present

Member of the Supervisory Board @Access to Medicine Foundation

Amsterdam, NL

The Foundation is working toward five strategic shifts in how pharmaceutical companies think and act regarding access to medicine. We use our three-part model for change:(1) we follow a consensus-building process to determine how companies can improve access to medicine;(2) we analyse how companies are performing in this regard; and (3) we engage with experts from across the industry and access-to-medicine space, for example, to improve companies’ long-term thinking on access and to increase the application of best practices.

EDUCATION

2014

China Europe International Business School (CEIBS)

Executive Program, China Regional Insights and Strategy Program

1975 — 1978

ESCP Business School

Masters, Business

2012

INSEAD

Executive Program, Advanced Business Strategy Program

2015

Singapore Management University

Executive Program, ASEAN Regional Insights Program

SKILLS

LeadershipMergers & AcquisitionsEntrepreneurshipConsultingHealthcareBusiness DevelopmentExecutive ManagementBusiness PlanningVenture CapitalBiotechnologyCorporate DevelopmentBusiness StrategyCompetitive AnalysisCross-Functional Team LeadershipStart-UpsRestructuringPharmaceutical IndustryBusiness Process ImprovementFinanceMarket ResearchCorporate FinanceLife SciencesStrategyStrategic PlanningStrategic ConsultingManagement ConsultingHuman ResourcesBusiness TransformationDue DiligenceChange ManagementAuditingLifesciencesFinancial Modeling

ABOUT PATRICK FLOCHEL

Our biggest challenge today is: how can we redesign global health systems to be efficient, sustainable and equitable? How can the private sector, government and agile entrepreneurs combine resources and expertise to develop health ecosystems of the future? I’m proud to having been part of a team developing new strategic direction for global life sciences companies. I have held global roles for 25 years, the past 18 of which have been in life sciences, leading the EY relationship with several of the largest pharma companies globally. I have sit on the EY sector leadership team and participated in the construction of EY’s point of view and strategic-level ideas about the evolution of the life sciences industry. As such I frequently spoke at global events and contributed to industry articles in the trade and general press.I think best by interacting with others and working with diverse groups; exploring paradox is the best way to progress big ideas.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.